Dr. Michelle Lofwall continued her involvement in the fight against the opioid epidemic by serving on a panel of experts developing guidelines for the use of FDA-approved medications for the treatment of opioid use disorder.
With the Markey Cancer Center, Ellingson uses molecular docking as a filtering process to efficiently and safely screen potential drugs before real-world experiments begin.
Professor Guoqiang Yu, and collaborators Dr. Elie G Abu Jawdeh and Dr. Henrietta S Bada, have been awarded a two-year grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health.
For the past four years, two junior faculty at UK have organized a symposium where outstanding scientists from UK and beyond present new scientific advances in women's heart health and explore translational cardiovascular research areas that merit further study.
Sixteen UK undergraduate researchers presented their research at the 17th annual Posters-at-the-Capitol in Frankfort on Feb. 8. Each had a chance to share their research with UK President Eli Capilouto as well as several state legislators.
In its ongoing efforts to offer Kentuckians the latest, most innovative cancer treatments available, the UK Markey Cancer Center recently launched the Precision Medicine Clinic, a new space dedicated to providing patients with increased access to phase I and phase II clinical trials.
The Markey Cancer Foundation invites you to take an active role in furthering life-changing cancer research at the University of Kentucky Markey Cancer Center through the 'Markey Women Strong' program.
Dr. Craig Van Horne, neurosurgeon, and Dr. George Quintero, DBS neurophysiologist at UK HealthCare's Neuroscience Institute, discuss deep brain stimulation in Sunday's Herald-Leader Your Health column.
